Creators of the OpenEvidence AI data aggregation tool have partnered with the New England Journal of Medicine to provide 35 ...

It is a challenging time to be a women’s health care provider, but there are ways physicians can reclaim their power while ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

On Thursday, the “Make America Healthy Again” commission released its first report on the potential contributors of chronic ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

After a heart attack, patients with ADHD may have poorer outcomes due to low participation in follow-ups and behavioral risk ...

A subretinal injection of ATSN-201 gene therapy demonstrated promising results in patients with X-linked retinoschisis in a ...

A machine learning model may be reliable for determining risk for postpartum depression, underscoring the need for greater ...

Shakira J. Grant, MBBS, MSCR, is working to make visible the lived experiences and real-world barriers that patients with ...

During his presidential inauguration at the ACOG Annual Clinical & Scientific Meeting, Steven J. Fleischman, MD, MBA, FACOG, ...

Studies are needed to assess the delivery and efficacy of psychoeducation programs focused on the menopause transition for ...